As indicated in Fig. 1, tumors with elevated levels of MALAT1 also show a higher propensity for lymph node metastasis, disease recurrence, and therapeutic failure in patients with prostate cancer. Here, MALAT1 is linked to metastatic malignant neoplasm in the lymph nodes.